Back to moneycontrol.com
My Space
Home
Price when posted : BSE: Rs 1171.45 ( 0.80 % ), NSE: Rs. 1169.95 ( 0.52 % )
Source:Forbes - Image via CrunchBase In the fall fo 2010, Pfizer trumpeted the purchase of a small, privately held drugmaker called FoldRx Pharmaceuticals, which developed its own discovery platform technology and was completing testing for it ... See more
10.26 AM May 24th
- Reply |
- Rate |
- Click if offensive |
- Share |
- Repost
Price when posted : [Pfizer - BSE:Rs. 1162.10 NSE:Rs. 1163.95 ]
6.24 PM May 23rd
- Reply |
- Rate |
- Click if offensive |
- Share |
- Repost
Price when posted : BSE: Rs 1170.00 ( -0.70 % ), NSE: Rs. 1163.95 ( -1.00 % )
3.39 PM May 23rd
- Reply |
- Rate |
- Click if offensive |
- Share |
- Repost
Price when posted : BSE: Rs 1180.00 ( 0.15 % ), NSE: Rs. 1178.45 ( 0.24 % )
12.59 PM May 23rd
- Reply |
- Rate |
- Click if offensive |
- Share |
- Repost
Price when posted : BSE: Rs 1178.00 ( -0.02 % ), NSE: Rs. 1175.00 ( -0.06 % )
Source:DNA India - U.S. drug reviewers on Tuesday recommended rejecting a Pfizer Inc drug because the data did not prove it worked well in treating a rare neurodegenerative disease. The U.S. Food and Drug Administration staff reviewed the pill, ... See more
10.47 AM May 23rd
- Reply |
- Rate |
- Click if offensive |
- Share |
- Repost
Have a query for the moderator? Click here to post your message and get an instant reply!
Price when posted : BSE: Rs 1178.00 ( -0.02 % ), NSE: Rs. 1176.00 ( 0.03 % )
Source:Wall Street Journal - By Jennifer Corbett Dooren Of DOW JONES NEWSWIRES WASHINGTON (Dow Jones)--A Food and Drug Administration medical reviewer recommended the agency not approve a drug developed by a Pfizer Inc. (PFE) subsidiary to treat... See more
10.26 AM May 23rd
- Reply |
- Rate |
- Click if offensive |
- Share |
- Repost
Price when posted : [Pfizer - BSE:Rs. 1178.20 NSE:Rs. 1175.65 ]
2.33 PM May 22nd
- Reply |
- Rate |
- Click if offensive |
- Share |
- Repost
Price when posted : BSE: Rs 1181.10 ( -1.38 % ), NSE: Rs. 1180.00 ( -1.19 % )
Source:Business Standard - Pharma major Pfizer Ltd registered net profit of Rs 48.10 crore in the quarter ended March 2012 as against Rs 63.14 crore during the four-month period ended March 2011, the company said on Monday. Its sales stood at Rs... See more
10.32 AM May 22nd
- Reply |
- Rate |
- Click if offensive |
- Share |
- Repost
Price when posted : BSE: Rs 1181.00 ( -1.39 % ), NSE: Rs. 1182.00 ( -1.03 % )
Source:The Hindu BusinessLine - Weeks after its $350-million marketing deal with Pfizer to sell its insulin products globally was called off, Biocon said it was still interested in partnering with the MNC in other areas. The over Rs 2,000-crore... See more
10.23 AM May 22nd
- Reply |
- Rate |
- Click if offensive |
- Share |
- Repost
Price when posted : [Pfizer - BSE:Rs. 1197.65 NSE:Rs. 1194.25 ]
Pfizer Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 21, 2012 appointed the following Additional Directors on the board of the Company with effect from May 21, 2012:1. Mr. Uday Khanna.... See more
3.49 PM May 21st
- Reply |
- Rate |
- Click if offensive |
- Share |
- Repost
OUR WINNING PICKS - DID YOU INVEST? subscribe now
INTRADAY PICKS! (May 29, 2012)
ALL TIME WINNERS
Multibaggers are compelling, undervalued investments giving enormous returns to thousands of our subscribers consistently.
Balasore Alloys
RECO PRICE
6
18 Oct 2006
Peak PRICE
1925 31983.33%
South Indian Bank
RECO PRICE
10
08 Oct 2008
Peak PRICE
1925 19423.33%
Sah Petroleums
RECO PRICE
14
21 Oct 2008
Peak PRICE
1925 13268.06%
Jyoti Ltd
RECO PRICE
34
15 Jul 2009
Peak PRICE
1925 5545.16%
Marg Ltd
RECO PRICE
34
05 Dec 2008
Peak PRICE
1925 5495.93%
Coromandel Fertiliser
RECO PRICE
36
12 Oct 2006
Peak PRICE
1925 5322.54%
Arvind Limited
RECO PRICE
44
01 Oct 2010
Peak PRICE
1925 4265.08%
Pitti Laminations
RECO PRICE
45
11 May 2010
Peak PRICE
1925 4192.08%
Shasun Chemicals and Drug
RECO PRICE
52
28 Apr 2008
Peak PRICE
1925 3619.81%
PFIZER NETWORK
Pharmaceuticals stocks
Explore Messageboard
